LOADING
Comparing Procter & Gamble (PG) and Thermo Fisher Scientific (TMO) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PG | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $333.8B | $191.0B |
| P/E Ratio | 21.2 | 29.0 |
| Forward P/E | 19.4 | 21.2 |
| PEG Ratio | 3.88 | 1.94 |
| EPS | $6.75 | $17.73 |
| Revenue Growth (YoY) | 1.5% | 7.2% |
| Profit Margin | 19.3% | 15.0% |
| Return on Equity | 31.6% | 13.0% |
| Dividend Yield | 2.93% | 0.33% |
| Beta | 0.40 | 0.97 |
| 52-Week High | $167.46 | $643.35 |
| 52-Week Low | $136.65 | $384.44 |
| Volume | -- | -- |
Procter & Gamble is the larger company by market capitalization. Procter & Gamble trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Procter & Gamble offers a higher dividend yield for income investors. Procter & Gamble has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.